tirzepatide and cancer risk In a promising new study, the widely used weight-loss drug tirzepatide—known commercially as Mounjaro for diabetes Zepbound for obesity—has shown a surprising secondary benefit: shrinking breast tumors in obese mice ⚠️Cancer Concerns Around Popular Weight-Loss
Pay in 4 interest-free payments of $6.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24




























